Bioactive glass versus autologous platelet-rich fibrin for treating periodontal intrabony defects: A comparative clinical study
- PMID: 29386798
- PMCID: PMC5767987
- DOI: 10.4103/0972-124X.201628
Bioactive glass versus autologous platelet-rich fibrin for treating periodontal intrabony defects: A comparative clinical study
Abstract
Background: To compare treatment modalities: Open flap debridement (OFD) alone (Group I), OFD in combination with PerioGlas® (Group II), and OFD in combination with autologous platelet-rich fibrin (PRF) (Group III) for periodontal intrabony defects (IBDs).
Aim: To evaluate on clinical and radiographic basis, effectiveness of PerioGlas®, and PRF in treating IBDs.
Settings and design: IBDs selected on the basis of the inclusion criteria were randomly assigned to Groups I, II, and III by coin toss method.
Materials and methods: The study was conducted on patients reporting to the department of periodontology and oral implantology. Thirty-eight patients with ninety periodontal IBDs of moderate to severe periodontitis were selected and assigned to Groups I, II, and III. In each patient, a minimum number of two sextants were present with pocket depths ≥5 mm in at least three teeth.
Statistical analysis: Statistical analysis based on mean values, standard deviation, and P values.
Results: Compared to baseline, 9 months postoperatively: (1) mean probing pocket depth reduction for Group I was 3.68 mm ± 0.72, for Group II was 5.57 mm ± 1.10, and for Group III was 6.11 mm ± 0.92. (2) The mean relative attachment level gain for Group I was 4.14 mm ± 0.76, for Group II was 6.57 mm ± 1.45, and for Group III was 6.74 mm ± 1.55. (3) Mean radiographic IBD fill for Group I was 69.29% mm ± 7.73, for Group II was 74.44% mm ± 8.57, and for Group III was 75.01% mm ± 7.85.
Conclusion: This study shows marked improvements in the clinical parameters and radiographic outcomes with both PerioGlas® and autologous PRF to treat periodontal IBDs as compared to OFD alone.
Keywords: Autologous platelet-rich fibrin; bioactive glass (PerioGlas®); intrabony defects; open flap debridement.
Conflict of interest statement
There are no conflicts of interest.
Figures


Similar articles
-
Treatment of periodontal intrabony defects using autologous platelet-rich fibrin and titanium platelet-rich fibrin: a randomized, clinical, comparative study.J Investig Clin Dent. 2017 Aug;8(3). doi: 10.1111/jicd.12231. Epub 2016 Jul 31. J Investig Clin Dent. 2017. PMID: 27477110 Clinical Trial.
-
Platelet-rich fibrin with 1% metformin for the treatment of intrabony defects in chronic periodontitis: a randomized controlled clinical trial.J Periodontol. 2015 Jun;86(6):729-37. doi: 10.1902/jop.2015.140646. Epub 2015 Mar 12. J Periodontol. 2015. PMID: 25762357 Clinical Trial.
-
Platelet-Rich Fibrin Combined With a Porous Hydroxyapatite Graft for the Treatment of 3-Wall Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial.J Periodontol. 2017 Dec;88(12):1288-1296. doi: 10.1902/jop.2012.110722. J Periodontol. 2017. PMID: 29314065 Clinical Trial.
-
Actual quantitative attachment gain secondary to use of autologous platelet concentrates in the treatment of intrabony defects: A meta-analysis.J Indian Soc Periodontol. 2019 May-Jun;23(3):190-202. doi: 10.4103/jisp.jisp_498_18. J Indian Soc Periodontol. 2019. PMID: 31142999 Free PMC article. Review.
-
Use of Platelet-Rich Fibrin in the Treatment of Periodontal Intrabony Defects: A Systematic Review and Meta-Analysis.Biomed Res Int. 2021 Feb 4;2021:6669168. doi: 10.1155/2021/6669168. eCollection 2021. Biomed Res Int. 2021. Retraction in: Biomed Res Int. 2024 Mar 20;2024:9838732. doi: 10.1155/2024/9838732. PMID: 33614786 Free PMC article. Retracted.
Cited by
-
Comparative evaluation of growth factors from platelet concentrates: An in vitro study.J Indian Soc Periodontol. 2019 Jul-Aug;23(4):322-328. doi: 10.4103/jisp.jisp_678_18. J Indian Soc Periodontol. 2019. PMID: 31367128 Free PMC article.
-
Use of platelet-rich fibrin for the treatment of periodontal intrabony defects: a systematic review and meta-analysis.Clin Oral Investig. 2021 May;25(5):2461-2478. doi: 10.1007/s00784-021-03825-8. Epub 2021 Feb 20. Clin Oral Investig. 2021. PMID: 33609186 Free PMC article.
-
Autogenous platelet concentrates for treatment of intrabony defects-A systematic review with meta-analysis.Periodontol 2000. 2025 Feb;97(1):153-190. doi: 10.1111/prd.12598. Epub 2024 Oct 19. Periodontol 2000. 2025. PMID: 39425513 Free PMC article.
-
Autologous platelet concentrates for treating periodontal infrabony defects.Cochrane Database Syst Rev. 2018 Nov 26;11(11):CD011423. doi: 10.1002/14651858.CD011423.pub2. Cochrane Database Syst Rev. 2018. PMID: 30484284 Free PMC article.
-
Regeneration of periodontal intrabony defects using platelet-rich fibrin (PRF): a systematic review and network meta-analysis.Odontology. 2024 Oct;112(4):1047-1068. doi: 10.1007/s10266-024-00949-7. Epub 2024 May 21. Odontology. 2024. PMID: 38771493 Free PMC article.
References
-
- Papapanou PN, Tonetti MS. Diagnosis and epidemiology of periodontal osseous lesions. Periodontol 2000. 2000;22:8–21. - PubMed
-
- Schallon RA. Diagnosis and management of vertical bone defects in periodontal disease. Gen Dent. 2012;60:290–7. - PubMed
-
- Wang HL, Greenwell H. Surgical periodontal therapy. Periodontol 2000. 2001;25:89–99. - PubMed
-
- Villar CC, Cochran DL. Regeneration of periodontal tissues: Guided tissue regeneration. Dent Clin North Am. 2010;54:73–92. - PubMed
-
- Graziani F, Gennai S, Cei S, Cairo F, Baggiani A, Miccoli M, et al. Clinical performance of access flap surgery in the treatment of the intrabony defect. A systematic review and meta-analysis of randomized clinical trials. J Clin Periodontol. 2012;39:145–56. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources